Should You Sell Ginkgo Bioworks Holdings Inc (DNA) Stock Friday Morning?

Ginkgo Bioworks Holdings Inc (DNA) has fallen Friday morning, with the stock declining -3.08% in pre-market trading to 3.15. DNA's short-term technical score of 62 indicates that the stock has traded more bullishly over the last month than 62% of stocks on the market. In the Biotechnology industry, which ranks 119 out of 146 industries, DNA ranks higher than 71% of stocks. Ginkgo Bioworks Holdings Inc has risen 0.93% over the past month, closing at $2.92 on July 22. During this period of time, the stock fell as low as $2.61 and as high as $4.91. DNA has an average analyst recommendation of Strong Buy. The company has an average price target of $8.26.

DNA has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on DNA!

See Full DNA Report

Ginkgo Bioworks Holdings Inc has a Long-Term Technical rank of 47. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 53% of the market scoring higher. In the Biotechnology industry which is number 83 by this metric, DNA ranks better than 83% of stocks.

Important Dates for Investors in DNA:

-Ginkgo Bioworks Holdings Inc is set to release earnings on 11/13/2022. Over the last 12 months, the company has reported EPS of $-2.07. -We do not have a set dividend date for Ginkgo Bioworks Holdings Inc at this time. Click Here To Get The Full Report on Ginkgo Bioworks Holdings Inc (DNA)